ETF Foundry Research (hypothetical) · rebalanced monthly
Every other metric on this page is the long-shortstrategy, which needs a short book. This fund is the long leg alone, so these are the figures for what it actually holds. The bottom-bucket number is that basket’s own return — not short P&L.
Gross of the placeholder expense ratio and trading costs · not investor results
Every constituent of the long leg — sort, search or filter by sector
| Ticker | Company | Sector | Market cap | Weight |
|---|---|---|---|---|
1UNH | UNITEDHEALTH GROUP INC | Healthcare | $363.01B | 22.96% |
2SNOW | SNOWFLAKE INC | Technology | $105.38B | 6.67% |
3GD | GENERAL DYNAMICS CORP | Industrials | $98.11B | 6.21% |
4HON | HONEYWELL INTERNATIONAL INC | Industrials | $70.91B | 4.49% |
5NXPI | NXP SEMICONDUCTORS NV | Technology | $67.37B | 4.26% |
6NDAQ | NASDAQ INC | Financial Services | $60.30B | 3.81% |
7WDAY | WORKDAY INC | Technology | $45.94B | 2.91% |
8MLM | MARTIN MARIETTA MATERIALS INC | Basic Materials | $36.79B | 2.33% |
9CNC | CENTENE CORP | Healthcare | $34.79B | 2.20% |
10COIN | COINBASE GLOBAL INC | Financial Services | $34.60B | 2.19% |
11DXCM | DEXCOM INC | Healthcare | $30.35B | 1.92% |
12ROIV | ROIVANT SCIENCES LTD | Healthcare | $28.98B | 1.83% |
13ECHO | ECHOSTAR CORP | Communication Services | $28.55B | 1.81% |
14VRSN | VERISIGN INC | Technology | $28.03B | 1.77% |
15INSM | INSMED INC | Healthcare | $25.90B | 1.64% |
16UTHR | UNITED THERAPEUTICS CORP | Healthcare | $25.27B | 1.60% |
17DD | DUPONT DE NEMOURS INC | Basic Materials | $20.50B | 1.30% |
18NBIX | NEUROCRINE BIOSCIENCES INC | Healthcare | $17.15B | 1.08% |
19BTSG | BRIGHTSPRING HEALTH SERVICES INC | Healthcare | $14.22B | 0.90% |
20SITM | SITIME CORP | Technology | $14.22B | 0.90% |
21PCOR | PROCORE TECHNOLOGIES INC | Technology | $11.55B | 0.73% |
22HALO | HALOZYME THERAPEUTICS INC | Healthcare | $11.48B | 0.73% |
23PINS | PINTEREST INC | Communication Services | $10.97B | 0.69% |
24MOH | MOLINA HEALTHCARE INC | Healthcare | $10.95B | 0.69% |
25HUBS | HUBSPOT INC | Technology | $10.54B | 0.67% |
26PCVX | VAXCYTE INC | Healthcare | $10.24B | 0.65% |
27TTC | TORO CO | Industrials | $10.11B | 0.64% |
28KNX | KNIGHT-SWIFT TRANSPORTATION HOLDINGS INC | Industrials | $10.05B | 0.64% |
29MDGL | MADRIGAL PHARMACEUTICALS INC | Healthcare | $9.88B | 0.62% |
30OC | OWENS CORNING | Industrials | $9.06B | 0.57% |
31APPF | APPFOLIO INC | Technology | $7.90B | 0.50% |
32ALKS | ALKERMES PLC | Healthcare | $7.89B | 0.50% |
33RYTM | RHYTHM PHARMACEUTICALS INC | Healthcare | $7.62B | 0.48% |
34DBX | DROPBOX INC | Technology | $7.49B | 0.47% |
35TTD | TRADE DESK INC | Technology | $7.32B | 0.46% |
36IMVT | IMMUNOVANT INC | Healthcare | $7.25B | 0.46% |
37LNTH | LANTHEUS HOLDINGS INC | Healthcare | $6.62B | 0.42% |
38FLR | FLUOR CORP | Industrials | $6.35B | 0.40% |
39LGND | LIGAND PHARMACEUTICALS INC | Healthcare | $6.33B | 0.40% |
40LYFT | LYFT INC | Technology | $6.28B | 0.40% |
41WFRD | WEATHERFORD INTERNATIONAL PLC | Energy | $6.20B | 0.39% |
42MIDD | MIDDLEBY CORP | Industrials | $6.12B | 0.39% |
43DOCS | DOXIMITY INC | Healthcare | $5.92B | 0.37% |
44VRNS | VARONIS SYSTEMS INC | Technology | $5.66B | 0.36% |
45FBIN | FORTUNE BRANDS INNOVATIONS INC | Industrials | $5.64B | 0.36% |
46ENS | ENERSYS | Industrials | $5.33B | 0.34% |
47SRRK | SCHOLAR ROCK HOLDING CORP | Healthcare | $5.27B | 0.33% |
48PEGA | PEGASYSTEMS INC | Technology | $5.24B | 0.33% |
49LKQ | LKQ CORP | Consumer Cyclical | $4.97B | 0.31% |
50GFF | GRIFFON CORP | Industrials | $4.75B | 0.30% |
51IONS | IONIS PHARMACEUTICALS INC | Healthcare | $4.55B | 0.29% |
52QTWO | Q2 HOLDINGS INC | Technology | $4.51B | 0.29% |
53MTRN | MATERION CORP | Basic Materials | $4.34B | 0.27% |
54BBWI | BATH & BODY WORKS INC | Consumer Cyclical | $4.25B | 0.27% |
55LION | LIONSGATE STUDIOS CORP | Communication Services | $4.20B | 0.27% |
56CDNA | CAREDX INC | Healthcare | $4.19B | 0.27% |
57OLED | UNIVERSAL DISPLAY CORP | Technology | $4.05B | 0.26% |
58TARS | TARSUS PHARMACEUTICALS INC | Healthcare | $3.79B | 0.24% |
59PRIM | PRIMORIS SERVICES CORP | Industrials | $3.76B | 0.24% |
60NATL | NCR ATLEOS CORP | Technology | $3.57B | 0.23% |
61ENPH | ENPHASE ENERGY INC | Technology | $3.54B | 0.22% |
62RGTI | RIGETTI COMPUTING INC | Technology | $3.54B | 0.22% |
63VKTX | VIKING THERAPEUTICS INC | Healthcare | $3.52B | 0.22% |
64ASH | ASHLAND INC | Basic Materials | $3.45B | 0.22% |
65FRSH | FRESHWORKS INC | Technology | $3.32B | 0.21% |
66HOG | HARLEY-DAVIDSON INC | Consumer Cyclical | $3.28B | 0.21% |
67REZI | RESIDEO TECHNOLOGIES INC | Industrials | $3.27B | 0.21% |
68IRTC | IRHYTHM HOLDINGS INC | Healthcare | $3.15B | 0.20% |
69TDC | TERADATA CORP | Technology | $3.12B | 0.20% |
70DNLI | DENALI THERAPEUTICS INC | Healthcare | $3.03B | 0.19% |
71IPGP | IPG PHOTONICS CORP | Technology | $3.01B | 0.19% |
72LOPE | GRAND CANYON EDUCATION INC | Consumer Defensive | $3.00B | 0.19% |
73UNFI | UNITED NATURAL FOODS INC | Consumer Defensive | $2.87B | 0.18% |
74WOR | WORTHINGTON ENTERPRISES INC | Industrials | $2.87B | 0.18% |
75XNCR | XENCOR INC | Healthcare | $2.86B | 0.18% |
76PGNY | PROGYNY INC | Healthcare | $2.69B | 0.17% |
77POWI | POWER INTEGRATIONS INC | Technology | $2.57B | 0.16% |
78RCUS | ARCUS BIOSCIENCES INC | Healthcare | $2.56B | 0.16% |
79SDGR | SCHRODINGER INC | Healthcare | $2.32B | 0.15% |
80DAN | DANA INC | Consumer Cyclical | $2.27B | 0.14% |
81PRGO | PERRIGO CO PLC | Healthcare | $2.25B | 0.14% |
82PPTA | PERPETUA RESOURCES CORP | Basic Materials | $2.23B | 0.14% |
83ASAN | ASANA INC | Technology | $2.21B | 0.14% |
84LEU | CENTRUS ENERGY CORP | Energy | $2.14B | 0.14% |
85BHVN | BIOHAVEN LTD | Healthcare | $2.13B | 0.13% |
86PBI | PITNEY BOWES INC | Industrials | $2.12B | 0.13% |
87CPRI | CAPRI HOLDINGS LTD | Consumer Cyclical | $2.11B | 0.13% |
88VERA | VERA THERAPEUTICS INC | Healthcare | $2.10B | 0.13% |
89REPL | REPLIMUNE GROUP INC | Healthcare | $2.08B | 0.13% |
90VIR | VIR BIOTECHNOLOGY INC | Healthcare | $2.08B | 0.13% |
91AI | C3AI INC | Technology | $1.94B | 0.12% |
92AGIO | AGIOS PHARMACEUTICALS INC | Healthcare | $1.90B | 0.12% |
93CLSK | CLEANSPARK INC | Financial Services | $1.76B | 0.11% |
94SRPT | SAREPTA THERAPEUTICS INC | Healthcare | $1.72B | 0.11% |
95RARE | ULTRAGENYX PHARMACEUTICAL INC | Healthcare | $1.66B | 0.10% |
96ABSI | ABSCI CORP | Healthcare | $1.57B | 0.10% |
97CXM | SPRINKLR INC | Technology | $1.54B | 0.10% |
98NTLA | INTELLIA THERAPEUTICS INC | Healthcare | $1.48B | 0.09% |
99PCRX | PACIRA BIOSCIENCES INC | Healthcare | $1.46B | 0.09% |
100NVAX | NOVAVAX INC | Healthcare | $1.45B | 0.09% |
101ANAB | ANAPTYSBIO INC | Healthcare | $1.43B | 0.09% |
102WOLF | WOLFSPEED INC | Technology | $1.42B | 0.09% |
103NVCR | NOVOCURE LTD | Healthcare | $1.37B | 0.09% |
104VYX | NCR VOYIX CORP | Technology | $1.35B | 0.09% |
105TRS | TRIMAS CORP | Consumer Cyclical | $1.35B | 0.09% |
106CMPS | COMPASS PATHWAYS PLC | Healthcare | $1.29B | 0.08% |
107NBR | NABORS INDUSTRIES LTD | Energy | $1.26B | 0.08% |
108UPWK | UPWORK INC | Industrials | $1.24B | 0.08% |
109YELP | YELP INC | Communication Services | $1.10B | 0.07% |
110MYE | MYERS INDUSTRIES INC | Consumer Cyclical | $1.07B | 0.07% |
111XPEL | XPEL INC | Consumer Cyclical | $1.04B | 0.07% |
112CBLL | CERIBELL INC | Healthcare | $1.02B | 0.06% |
113CYRX | CRYOPORT INC | Industrials | $1.02B | 0.06% |
114KRO | KRONOS WORLDWIDE INC | Basic Materials | $968M | 0.06% |
115CMP | COMPASS MINERALS INTERNATIONAL INC | Basic Materials | $968M | 0.06% |
116AOSL | ALPHA & OMEGA SEMICONDUCTOR LTD | Technology | $926M | 0.06% |
117MMI | MARCUS & MILLICHAP INC | Real Estate | $920M | 0.06% |
118ROCK | GIBRALTAR INDUSTRIES INC | Industrials | $918M | 0.06% |
119SXC | SUNCOKE ENERGY INC | Basic Materials | $913M | 0.06% |
120PSIX | POWER SOLUTIONS INTERNATIONAL INC | Industrials | $909M | 0.06% |
121BBNX | BETA BIONICS INC | Healthcare | $898M | 0.06% |
122CODI | COMPASS DIVERSIFIED HOLDINGS | Industrials | $888M | 0.06% |
123NX | QUANEX BUILDING PRODUCTS CORP | Industrials | $886M | 0.06% |
124ORIC | ORIC PHARMACEUTICALS INC | Healthcare | $881M | 0.06% |
125RIGL | RIGEL PHARMACEUTICALS INC | Healthcare | $860M | 0.05% |
126CRTO | CRITEO SA | Communication Services | $858M | 0.05% |
127MITK | MITEK SYSTEMS INC | Technology | $824M | 0.05% |
128FMC | FMC CORP | Basic Materials | $787M | 0.05% |
129ULH | UNIVERSAL LOGISTICS HOLDINGS INC | Industrials | $783M | 0.05% |
130JANX | JANUX THERAPEUTICS INC | Healthcare | $703M | 0.04% |
131SWBI | SMITH & WESSON BRANDS INC | Industrials | $698M | 0.04% |
132FLGT | FULGENT GENETICS INC | Healthcare | $694M | 0.04% |
133KURA | KURA ONCOLOGY INC | Healthcare | $683M | 0.04% |
134SGMT | SAGIMET BIOSCIENCES INC | Healthcare | $679M | 0.04% |
135PKOH | PARK OHIO HOLDINGS CORP | Industrials | $679M | 0.04% |
136LEGH | LEGACY HOUSING CORP | Consumer Cyclical | $675M | 0.04% |
137ZVRA | ZEVRA THERAPEUTICS INC | Healthcare | $664M | 0.04% |
138DNA | GINKGO BIOWORKS HOLDINGS INC | Healthcare | $663M | 0.04% |
139CGEM | CULLINAN THERAPEUTICS INC | Healthcare | $662M | 0.04% |
140SRZN | SURROZEN INC | Healthcare | $604M | 0.04% |
141MATW | MATTHEWS INTERNATIONAL CORP | Industrials | $590M | 0.04% |
142EGY | VAALCO ENERGY INC | Energy | $582M | 0.04% |
143MLR | MILLER INDUSTRIES INC | Consumer Cyclical | $551M | 0.03% |
144TITN | TITAN MACHINERY INC | Industrials | $550M | 0.03% |
145SBC | SBC MEDICAL GROUP HOLDINGS INC | Industrials | $549M | 0.03% |
146MYGN | MYRIAD GENETICS INC | Healthcare | $545M | 0.03% |
147PKE | PARK AEROSPACE CORP | Industrials | $544M | 0.03% |
148RGNX | REGENXBIO INC | Healthcare | $531M | 0.03% |
149NTGR | NETGEAR INC | Technology | $527M | 0.03% |
150TKNO | ALPHA TEKNOVA INC | Healthcare | $522M | 0.03% |
151BBCP | CONCRETE PUMPING HOLDINGS INC | Industrials | $518M | 0.03% |
152SRTA | STRATA CRITICAL MEDICAL INC | Healthcare | $515M | 0.03% |
153RCEL | AVITA MEDICAL INC | Healthcare | $509M | 0.03% |
154DMAC | DIAMEDICA THERAPEUTICS INC | Healthcare | $503M | 0.03% |
155HY | HYSTER-YALE INC | Industrials | $501M | 0.03% |
156ASPN | ASPEN AEROGELS INC | Industrials | $498M | 0.03% |
157WNC | WABASH NATIONAL CORP | Industrials | $477M | 0.03% |
158ZIP | ZIPRECRUITER INC | Industrials | $461M | 0.03% |
159ARVN | ARVINAS INC | Healthcare | $450M | 0.03% |
160SI | SHOULDER INNOVATIONS INC | Healthcare | $441M | 0.03% |
161BNED | BARNES & NOBLE EDUCATION INC | Consumer Cyclical | $440M | 0.03% |
162CLFD | CLEARFIELD INC | Technology | $425M | 0.03% |
163PRTA | PROTHENA CORP PUBLIC LTD CO | Healthcare | $423M | 0.03% |
164VITL | VITAL FARMS INC | Consumer Defensive | $385M | 0.02% |
165LYEL | LYELL IMMUNOPHARMA INC | Healthcare | $385M | 0.02% |
166SPIR | SPIRE GLOBAL INC | Industrials | $375M | 0.02% |
167ERII | ENERGY RECOVERY INC | Industrials | $364M | 0.02% |
168MEC | MAYVILLE ENGINEERING COMPANY INC | Industrials | $357M | 0.02% |
169TMCI | TREACE MEDICAL CONCEPTS INC | Healthcare | $350M | 0.02% |
170MKTW | MARKETWISE INC | Technology | $350M | 0.02% |
171CHPT | CHARGEPOINT HOLDINGS INC | Consumer Cyclical | $324M | 0.02% |
172AGEN | AGENUS INC | Healthcare | $311M | 0.02% |
173EBS | EMERGENT BIOSOLUTIONS INC | Healthcare | $303M | 0.02% |
174MLP | MAUI LAND & PINEAPPLE CO INC | Real Estate | $299M | 0.02% |
175TBCH | TURTLE BEACH CORP | Technology | $296M | 0.02% |
176PMTS | CPI CARD GROUP INC | Financial Services | $293M | 0.02% |
177UCFI | CN HEALTHY FOOD TECH GROUP CORP | Consumer Defensive | $288M | 0.02% |
178GTERA | GLOBA TERRA ACQUISITION CORP | Financial Services | $249M | 0.02% |
179ASLE | AERSALE CORP | Industrials | $245M | 0.02% |
180SOCA | SOLARIUS CAPITAL ACQUISITION CORP | Financial Services | $245M | 0.02% |
181ARCT | ARCTURUS THERAPEUTICS HOLDINGS INC | Healthcare | $243M | 0.02% |
182AOUT | AMERICAN OUTDOOR BRANDS INC | Consumer Cyclical | $240M | 0.02% |
183IMMR | IMMERSION CORP | Technology | $231M | 0.01% |
184DTIL | PRECISION BIOSCIENCES INC | Healthcare | $225M | 0.01% |
185AVNW | AVIAT NETWORKS INC | Technology | $218M | 0.01% |
186VRA | VERA BRADLEY INC | Consumer Cyclical | $217M | 0.01% |
187PDEX | PRO DEX INC | Healthcare | $216M | 0.01% |
188TRDA | ENTRADA THERAPEUTICS INC | Healthcare | $202M | 0.01% |
189DIBS | 1STDIBSCOM INC | Consumer Cyclical | $199M | 0.01% |
190KRRO | KORRO BIO INC | Healthcare | $196M | 0.01% |
191IMXI | INTERNATIONAL MONEY EXPRESS INC | Technology | $193M | 0.01% |
192ALTG | ALTA EQUIPMENT GROUP INC | Industrials | $186M | 0.01% |
193QUIK | QUICKLOGIC CORP | Technology | $182M | 0.01% |
194RAIL | FREIGHTCAR AMERICA INC | Industrials | $175M | 0.01% |
195FC | FRANKLIN COVEY CO | Industrials | $168M | 0.01% |
196DMRC | DIGIMARC CORP | Technology | $167M | 0.01% |
197COOK | TRAEGER INC | Consumer Cyclical | $162M | 0.01% |
198AP | AMPCO PITTSBURGH CORP | Industrials | $159M | 0.01% |
199HOFT | HOOKER FURNISHINGS CORP | Consumer Cyclical | $156M | 0.01% |
200ALMU | AELUMA INC | Technology | $146M | 0.01% |
201SRI | STONERIDGE INC | Consumer Cyclical | $145M | 0.01% |
202CUE | CUE BIOPHARMA INC | Healthcare | $127M | 0.01% |
203SPRB | SPRUCE BIOSCIENCES INC | Healthcare | $123M | 0.01% |
204BYND | BEYOND MEAT INC | Consumer Defensive | $102M | 0.01% |
205LAKE | LAKELAND INDUSTRIES INC | Consumer Cyclical | $92M | 0.01% |
206JYNT | JOINT CORP | Healthcare | $92M | 0.01% |
207RLYB | RALLYBIO CORP | Healthcare | $84M | 0.01% |
208BARK | BARK INC | Consumer Cyclical | $81M | 0.01% |
209ATRA | ATARA BIOTHERAPEUTICS INC | Healthcare | $81M | 0.01% |
210FTLF | FITLIFE BRANDS INC | Consumer Defensive | $78M | 0.00% |
211NRDY | NERDY INC | Technology | $76M | 0.00% |
212NTIC | NORTHERN TECHNOLOGIES INTERNATIONAL CORP | Basic Materials | $74M | 0.00% |
213GOSS | GOSSAMER BIO INC | Healthcare | $69M | 0.00% |
214PRTS | CARPARTSCOM INC | Consumer Cyclical | $68M | 0.00% |
215LFVN | LIFEVANTAGE CORP | Consumer Defensive | $64M | 0.00% |
216XLO | XILIO THERAPEUTICS INC | Healthcare | $58M | 0.00% |
217TRT | TRIO-TECH INTERNATIONAL | Technology | $55M | 0.00% |
218YARW | YARROW BIOSCIENCE INC | Healthcare | $52M | 0.00% |
Full long-leg book as of November 2026 · cap-weighted · total market cap $1.58T. Hypothetical model holdings — not a registered fund’s portfolio.
Size × value map of the long-leg book
How this book measures against the concentration and liquidity rules — as implemented here
These are UNCONSTRAINED factor sleeves: the construction pipeline sorts on a signal and cap-weights the top bucket, applying no issuer cap, no industry cap and no liquidity screen beyond the universe filter. A failing test therefore reports a constraint that was never applied during construction — it is not a defect in the strategy and not an error in the data. The same signal can be solved subject to these constraints.
7 independent checks plus 1 arithmetically implied by another check (RIC / IRC 851(b)(3)(A) 50% bucket), which is reported separately so the tally cannot overstate scrutiny.
2 of 7 checks could not be tested. Those are neither passes nor failures — they are gaps in what the data can answer, and they are excluded from the passed count above rather than folded into it.
The fund will not concentrate: no more than 25% of total assets in any one industry (excluding government securities and cash items).
Close to the line. The engine flags this verdict as one a routine data rebuild could flip. Read it as borderline rather than settled — the margin beside it is the whole story.
Days required to liquidate the largest position at 20% of one day's dollar volume.
Engineering approximation of the cited rules for a DRAFT / HYPOTHETICAL model portfolio that is not a registered fund. This reports whether the portfolio passes the stated test AS IMPLEMENTED HERE; it is not a compliance opinion and is not a statement that any fund is compliant. Real filings need securities counsel.
1 verdict(s) sit within 1.0pp of their limit and can be flipped by a routine data rebuild; do not headline them, and always show the margin.
Data version — panel=20261113T032607 rows=2198308 asof=202611 issuers=20261113T063725 rates=20261113T063725
Measured on the 2026-11 formation date across 218 holdings (cap-weighted). A different formation date can produce different verdicts.
Whether this long-only book is subject to the VaR tests at all
This assessment describes the long-only book this fund holds — the top bucket only.
This fund QUALIFIES for the limited-derivatives-user exception, so it is excepted from the VaR tests; the ratio below is informational, not the operative limit.
Rule 18f-4(c)(4): a fund whose derivatives exposure (gross notional, including the value of assets sold short) is <= 10% of net assets is excepted from the VaR tests and the full derivatives risk management program.
No confidence interval: this follows from portfolio construction, not from an estimate.
Rule 18f-4(c)(2)(i): fund VaR at 99% over 20 trading days must not exceed 200% of the designated reference portfolio's VaR on the same basis.
Informational — does not governThis fund is excepted from the VaR tests, so the ratio below is context rather than the operative limit. It is shown because it is still a description of the book’s risk, not because it decides anything.
historical method · 335 monthly observations · about 3.4 in the 99% tail · paired percentile bootstrap over months
The estimators differ materially in value but agree on the verdict. Historical and Gaussian fund VaR differ by 20%; both still land on the same side of the 2x limit.
Engineering approximation of SEC Rule 18f-4 for research display. Not a compliance opinion and not a determination that any fund is compliant. Hypothetical model portfolio, not a registered fund.
The research long-short construction behind this factor does not qualify for this exception — a dollar-neutral book counts its full short notional, which is 100% of net assets against a 10% threshold. This product sidesteps that by holding the long leg alone, which is also why the long-leg Sharpe is reported separately throughout the site.
See the long-short verdict on the factor page →Did the edge survive the paper coming out?
Split at January of the year after the factor was published. The post-publication stretch IS genuinely out-of-sample relative to the original study -- the predictor was public by then -- so it speaks to whether the effect survived being known. Nothing is fitted here, so this is performance SINCE PUBLICATION, not validation of a model. Note the 'pre' side is our data before publication (our panel starts ~1999), NOT the study's original in-sample period, which usually ran decades earlier; a decay figure compares before-vs-after within our sample and is not a comparison against the published result.
Is this record broadly durable, or one regime?
3-year rolling windows, stepping 1 year (26 windows). Dispersion is the spread of window Sharpes — higher means the record depends more on which era you look at.
Rules-based factors fit no parameters, so these windows are not out-of-sample tests and do not validate a fitted model. They show whether the factor's record is consistent across eras or driven by one regime.
Long leg is what this fund holds — long-short is shown for reference
| Period | Long leg | Long-short |
|---|---|---|
| 1 yearcum. | 28.3% | 38.3% |
| 3 yearsp.a. | 25.3% | -6.9% |
| 5 yearsp.a. | 14.5% | 1.4% |
| 10 yearsp.a. | 17.5% | -3.3% |
| Since inceptionp.a. | 8.7% | -5.0% |
| Year | Long leg | Long-short |
|---|---|---|
| 202611 mo | 29.6% | 44.1% |
| 2025 | 23.5% | -15.4% |
| 2024 | 13.2% | -35.9% |
| 2023 | 63.4% | 17.1% |
| 2022 | -32.5% | 11.5% |
| 2021 | 19.6% | -5.9% |
| 2020 | 35.9% | -6.5% |
| 2019 | 31.4% | -1.3% |
| 2018 | -8.7% | -7.8% |
| 2017 | 27.6% | -11.9% |
| 2016 | 8.6% | 2.9% |
| 2015 | 4.9% | 2.1% |
| 2014 | 14.8% | -4.1% |
| 2013 | 41.5% | -2.1% |
| 2012 | 17.2% | 12.5% |
| 2011 | 2.4% | 2.5% |
| 2010 | 25.2% | 12.2% |
| 2009 | 33.9% | -10.3% |
| 2008 | -39.9% | -6.6% |
| 2007 | 12.1% | -21.2% |
| 2006 | 13.9% | -8.5% |
| 2005 | -0.4% | -11.9% |
| 2004 | 2.2% | -9.6% |
| 2003 | 36.9% | 4.2% |
| 2002 | -40.8% | -25.8% |
| 2001 | -9.8% | 1.2% |
| 2000 | -30.4% | -13.0% |
| 1999 | 39.8% | -20.1% |
Long leg = the top bucket this fund holds; long-short additionally shorts the bottom bucket and is not achievable in a long-only vehicle. Trailing figures run through November 2026: 1 year is a plain cumulative 12-month return (cum.), 3 years and longer are annualised (p.a.). Years marked with a month count are partial. These match the fact sheet’s tables by construction. Hypothetical backtest, gross of the placeholder expense ratio and trading costs — not investor results.
The Foundry DelCOA Industry-Neutral Factor ETF tracks a rules-based model that ranks liquid U.S. common stocks, industry-neutralized within Fama-French industries, each month by a DelCOA signal and holds the top decile with the lowest values. Signals are computed from point-in-time Sharadar fundamentals and total-return prices. The portfolio reconstitutes monthly and is cap-weighted within the long leg.
This is a hypothetical model portfolio for research display only — not a registered fund, not an offer, and not investment advice.
Auto-generated from the model’s metrics and current holdings. Every document is labeled DRAFT / hypothetical.
Objective, fees, strategy, and key risks.
Full strategy, model methodology, and risks.
Policies, construction, and governance.
One-page snapshot with top holdings.
Full current constituent list.
DRAFT — HYPOTHETICAL MODEL PORTFOLIO — NOT A REGISTERED FUND, NOT AN OFFER TO SELL SECURITIES, NOT INVESTMENT ADVICE.
Share of long-leg capital by market cap × book-to-market, using terciles of the 3,140-name universe at November 2026. Rows: Large ≥ $5.3B, Small < $832M. Columns: Value ≥ 0.62, Growth < 0.33 B/M. The dot marks the capital-weighted centroid of the book — 92% toward Large, 69% toward Growth. +3% unclassified (19 missing size/value). Hypothetical holdings — descriptive, not realized P&L.
Capital-weighted centroid of the long leg, December 1998 → November 2026; the right-hand end is the same value as the box’s dot. 218 names now. Hypothetical holdings — descriptive, not P&L.